EntryPoint Capital’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,671
Closed -$233K 760
2025
Q1
$233K Buy
6,671
+1,184
+22% +$46.9K 0.11% 463
2024
Q4
$244K Buy
+5,487
New +$246K 0.1% 492
2024
Q3
Sell
-3,483
Closed -$94.3K 985
2024
Q2
$94.3K Buy
3,483
+1,028
+42% +$29.8K 0.14% 337
2024
Q1
$71.8K Buy
2,455
+1,345
+121% +$40.8K 0.06% 589
2023
Q4
$41.8K Buy
+1,110
New +$40.8K 0.04% 813

Other funds holding OMCL

EntryPoint Capital's OMCL Position: Q2 2025 in Review

EntryPoint Capital sold out of Omnicell (OMCL) in Q2 2025, closing a stake of 6,671 shares — an estimated $233K sold.

EntryPoint Capital first reported a position in OMCL in Q4 2023 and held it in 5 quarters. The position peaked at $244K in Q4 2024. 247 funds tracked by Wall St. Rank hold OMCL as of Q2 2025.

  • EntryPoint Capital reported no remaining Omnicell position as of Q2 2025 after selling out during the quarter.
  • EntryPoint Capital sold 6,671 Omnicell shares in Q2 2025, an estimated $233K.
  • EntryPoint Capital first reported a position in Omnicell in Q4 2023 and held it in 5 quarters.
  • EntryPoint Capital's Omnicell position peaked at $244K in Q4 2024.
  • 247 funds tracked by Wall St. Rank held Omnicell as of Q2 2025.

Based on EntryPoint Capital's 13F filing for Q2 2025, filed 11 Aug 2025.